Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia.

Blood - 23 Dec 2010

Imagawa Jun, Harada Yuka, Shimomura Takeshi, Tanaka Hideo, Okikawa Yoshiko, Hyodo Hideo, Kimura Akiro, Harada Hironori

Abstract excerpt

Acute promyelocytic leukemia (APL) is a highly curable disease with excellent complete remission and long-term survival rates. However, the development of therapy-related myeloid neoplasms (t-MN) is being reported with increasing frequency in patients successfully treated for APL. We attempted to clarify the different clinical features and hematologic findings between t-MN and relapse cases, and to identify gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to CCAAT-Enhancer-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Core Binding Factor Alpha 2 Subunit

Share to fms-Like Tyrosine Kinase 3

Share to Genes, ras

Share to Leukemia, Promyelocytic, Acute

Share to Neoplasms, Second Primary

Share to Survival Rate

Source

Identifiers

PMID: 20861459
DOI: 10.1182/blood-2010-06-289389

Genes

RUNX1
PML
RARA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemia.PMID 20861459Read ↗

PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASMSemantic proximity Read ↗

Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Therapy-Related Myeloid NeoplasmsSemantic proximity Read ↗

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia.Semantic proximity Read ↗

Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemiaSemantic proximity Read ↗

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.Semantic proximity Read ↗

Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation.Semantic proximity Read ↗

Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapseSemantic proximity Read ↗

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?Semantic proximity Read ↗

Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myelomaSemantic proximity Read ↗

All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status.Semantic proximity Read ↗

Clinical and pathologic features of secondary acute promyelocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.